Editorial: New and emerging lipid-lowering therapies for reducing cardiovascular risk: beyond statins

Front Cardiovasc Med. 2024 Jan 15:11:1364170. doi: 10.3389/fcvm.2024.1364170. eCollection 2024.
No abstract available

Keywords: ASCVD; LDL-C; PCSK9; cardiovascular risk; lipid-lowering therapies.

Publication types

  • Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article.